Diagnosis of TET3 ‐Related Beck–Fahrner Syndrome in an Individual With Chorioretinal and Iris Colobomata Using a DNA Methylation Signature
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.63864 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Alice Man und 8 weiteren Autor:innen. Beteiligte Einrichtung: Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Coloboma, DNA Methylation, Dioxygenases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ontario Genomics, Genome Canada.
Abstract (Originalsprache)
Disorders of developmental delay can occur from pathogenic variants in genes responsible for epigenetic regulation. Heterozygous and biallelic pathogenic variants in TET3 have recently been described in TET3 ‐related Beck–Fahrner syndrome ( TET3 ‐BEFAHRS), representing an autosomal dominant disorder with variable expressivity. Typical features include intellectual disability and developmental delay. Patients can also present with facial dysmorphism, seizure disorder, ophthalmic findings, and other neurobehavioral features. As the condition has recently been described and few patients have been reported in literature, the full scope of the phenotypic spectrum and approaches to identify them are still emerging. We report an individual meeting the criteria for TET3 ‐BEFAHRS confirmed through clinical, genetic, and DNA methylation episignature analysis, who uniquely presents with bilateral chorioretinal and unilateral right iris colobomata. This case suggests a broader ophthalmic phenotype to TET3 ‐BEFAHRS and demonstrates the utility of episignatures for the diagnosis of Mendelian disorders of epigenetic machinery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
- Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, Ontario, Canada.
- Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.
- Division of Genetics, Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
- Department of Pediatrics, McMaster Children's Hospital, Hamilton, Ontario, Canada.
- Department of Radiology, McMaster University, Hamilton, Ontario, Canada.
ORCID-Profile: Alice Man, Matteo Di Scipio, Christian R Marshall, Bekim Sadikovic, Resham Ejaz
Förderung
- Ontario Genomics
- Genome Canada
Zitieren
APA
Man, A., Di Scipio, M., McConkey, H., Hough, R., Stein, N., Diehl, E., Marshall, C. R., Sadikovic, B., & Ejaz, R. (2025). Diagnosis of TET3 ‐Related Beck–Fahrner Syndrome in an Individual With Chorioretinal and Iris Colobomata Using a DNA Methylation Signature. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63864
Vancouver
Man A, Di Scipio M, McConkey H, Hough R, Stein N, Diehl E, et al. Diagnosis of TET3 ‐Related Beck–Fahrner Syndrome in an Individual With Chorioretinal and Iris Colobomata Using a DNA Methylation Signature. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.63864
BibTeX
@article{Man2025,
author = {Man, Alice and Di Scipio, Matteo and McConkey, Haley and Hough, Rebecca and Stein, Nina and Diehl, Eric and Marshall, Christian R and Sadikovic, Bekim and Ejaz, Resham},
title = {Diagnosis of TET3 ‐Related Beck–Fahrner Syndrome in an Individual With Chorioretinal and Iris Colobomata Using a DNA Methylation Signature},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.63864}
}
EUVIMED